Assessing Pharmaceutical Research and Development Costs

被引：14

作者：

DiMasi, Joseph A. ^{[1
]}

机构：

[1] Tufts Univ, Tufts Ctr Study Drug Dev, 75 Kneeland St,Ste 1100, Boston, MA 02111 USA

来源：

JAMA INTERNAL MEDICINE | 2018年 / 178卷 / 04期

关键词：

D O I：

10.1001/jamainternmed.2017.8703

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：587 / 587

页数：1

共 50 条

[31] ACCOUNTING FOR RESEARCH AND DEVELOPMENT COSTS - THE IMPACT ON RESEARCH AND DEVELOPMENT EXPENDITURES
DUKES, RE
DYCKMAN, TR
ELLIOTT, JA
JOURNAL OF ACCOUNTING RESEARCH, 1980, 18 : 1 - 26
[32] Applications of proteomics in pharmaceutical research and development
Yokota, Hiroyuki
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2019, 1867 (01): : 17 - 21
[33] Nonprofit organizations and pharmaceutical research and development
Moos, Walter H.
Collins, Nathan
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
[34] PLANNING MODEL OF PHARMACEUTICAL RESEARCH AND DEVELOPMENT
COX, JSG
MILLANE, BV
STYLES, AEJ
R & D MANAGEMENT, 1975, 5 (03) : 219 - 227
[35] The determinants of pharmaceutical research and development expenditures
Henry Grabowski
John Vernon
Journal of Evolutionary Economics, 2000, 10 : 201 - 215
[36] The determinants of pharmaceutical research and development expenditures
Grabowski, H
Vernon, J
JOURNAL OF EVOLUTIONARY ECONOMICS, 2000, 10 (1-2) : 201 - 215
[37] The determinants of pharmaceutical research and development expenditures
Grabowski, H
Vernon, J
CAPITALISM AND DEMOCRACY IN THE 21ST CENTURY, 2001, : 207 - 221
[38] DEVELOPMENT OF INDUSTRIAL PHARMACEUTICAL RESEARCH IS ESSENTIAL
VIGNERON, M
PRODUCTS ET PROBLEMS PHARMACEUTIQUES, 1966, 21 (09): : 385 - &
[39] Nonprofit Organizations and Pharmaceutical Research and Development
Moos, Walter H.
Mirsalis, Jon C.
DRUG DEVELOPMENT RESEARCH, 2009, 70 (07) : 461 - 471
[40] Globalization of pharmaceutical research and development: A perspective
Desikan, Sridhar
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242

← 1 2 3 4 5 →